Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ARB”

181 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 181 results

Large-scale testing (Phase 3)Study completedNCT00857285
What this trial is testing

Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 130
Post-approval studies (Phase 4)Study completedNCT00666536
What this trial is testing

The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy

Who this might be right for
Hypertension
Novartis 728
Testing effectiveness (Phase 2)Study completedNCT02678000
What this trial is testing

Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function

Who this might be right for
Chronic Kidney Disease (CKD)
Novartis Pharmaceuticals 84
Large-scale testing (Phase 3)Study completedNCT00340678
What this trial is testing

Renoprotection in Early Diabetic Nephropathy in Pima Indians

Who this might be right for
Diabetic Nephropathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 170
Testing effectiveness (Phase 2)WithdrawnNCT03005184
What this trial is testing

Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2

Who this might be right for
Heart Failure NYHA Class IHeart Failure NYHA Class IIHeart Failure NYHA Class III
Vanderbilt University Medical Center
Post-approval studies (Phase 4)Study completedNCT00347087
What this trial is testing

Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure

Who this might be right for
Chronic Heart Failure
Charite University, Berlin, Germany 36
Large-scale testing (Phase 3)WithdrawnNCT00280215
What this trial is testing

Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

Who this might be right for
Hyperoxaluria
Mayo Clinic
Large-scale testing (Phase 3)Study completedNCT00199927
What this trial is testing

Statins in Proteinuric Nephropathies

Who this might be right for
Chronic NephropathyProteinuriaHypertension
Mario Negri Institute for Pharmacological Research 217
Not applicableUnknownNCT05329727
What this trial is testing

The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF

Who this might be right for
Heart FailureMortality
Wonju Severance Christian Hospital 1,000,000
Not applicableUnknownNCT00561327
What this trial is testing

PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites

Who this might be right for
Hypertension
German Heart Institute
Large-scale testing (Phase 3)Looking for participantsNCT05196035
What this trial is testing

Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

Who this might be right for
Chronic Kidney DiseaseProteinuria
Bayer 219
Large-scale testing (Phase 3)Study completedNCT02175355
What this trial is testing

Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)

Who this might be right for
Hypertension
Boehringer Ingelheim 1,039
Not applicableUnknownNCT05328310
What this trial is testing

Effect of Different Antihypertensive Drugs on Central Blood Pressure

Who this might be right for
Hypertension
Korea University Anam Hospital 110
Post-approval studies (Phase 4)Study completedNCT00149227
What this trial is testing

Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)

Who this might be right for
HypertensionIschemic Heart DiseaseCongestive Heart Failure+1 more
Kyoto Prefectural University of Medicine 3,031
Post-approval studies (Phase 4)UnknownNCT00407680
What this trial is testing

Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

Who this might be right for
Type 2 Diabetes MellitusHypertension
Kitasato University 80
Post-approval studies (Phase 4)UnknownNCT01011660
What this trial is testing

Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients

Who this might be right for
Essential Hypertension
Chinese Academy of Medical Sciences, Fuwai Hospital 13,542
Post-approval studies (Phase 4)UnknownNCT00949351
What this trial is testing

Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy

Who this might be right for
Type 2 Diabetes With Nephropathy
Lerdsin General Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01756716
What this trial is testing

Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR

Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 49
Not applicableStudy completedNCT03649646
What this trial is testing

FimasaRtan-basEd BP Targets After Drug SwitcHing

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 4,542
Not applicableStudy completedNCT00617877
What this trial is testing

Antihypertensive Response to Losartan and Genetic Polymorphisms

Who this might be right for
Hypertension
Merck Sharp & Dohme LLC 800
Load More Results